Join STAT reporters live today at 1 p.m. ET for a recap of the year's biggest ASCO presentations and their final takeaways from ASCO 2025.
AstraZeneca's Susan Galbraith will join to discuss the company's latest oncology studies.
Then, STAT reporters will reflect on Big Pharma's dominant presence at the meeting and share key themes and questions that stood out across the week — from evolving treatment strategies to policy concerns impacting funding, the scientific workforce, and the future of cancer research.
%20MH%20Testing/Larger%20Header%20Logos/STAT_Events2.png?height=88&upscale=true&name=STAT_Events2.png){kind=small}
%20MH%20Testing/Footer%20Icons/Flipboard-logo.png?width=60&height=60&upscale=true&name=Flipboard-logo.png){kind=logo}
%20MH%20Testing/Footer%20Icons/X-logo.png?width=60&height=60&upscale=true&name=X-logo.png){kind=logo}
%20MH%20Testing/Footer%20Icons/Linkedin-logo.png?width=60&height=60&upscale=true&name=Linkedin-logo.png){kind=logo}
%20MH%20Testing/Footer%20Icons/Facebook-logo.png?width=60&height=60&upscale=true&name=Facebook-logo.png){kind=logo}
%20MH%20Testing/Footer%20Icons/Youtube-logo.png?width=60&height=60&upscale=true&name=Youtube-logo.png){kind=logo}
%20MH%20Testing/Footer%20Icons/Instagram-logo.png?width=60&height=60&upscale=true&name=Instagram-logo.png){kind=logo}
%20MH%20Testing/Footer%20Icons/Threads-logo.png?width=60&height=60&upscale=true&name=Threads-logo.png){kind=logo}
No comments